[[{“value”:”
-11.85%
-66.50%
08:49am
Tilray Medical Introduces Cannabis Edibles In Australia
RE
08:29am
Tilray Brands Subsidiary Introduces Cannabis Edibles in Australia; Tilray Seeks Approval for Reverse Stock Split
MT
April 17, 2025 at 08:29 am EDT
© MT Newswires – 2025
Latest news about Tilray Brands, Inc.
Tilray Medical Introduces Cannabis Edibles In Australia
08:49am
RE
Tilray Brands Subsidiary Introduces Cannabis Edibles in Australia; Tilray Seeks Approval for Reverse Stock Split
08:29am
MT
Tilray Brands Shareholders to Vote on Reverse Stock Split Proposal on June 10
08:19am
MT
Tilray Brief: Tilray Medical Introducing Cannabis Edibles in Australia
08:11am
MT
Tilray to Seek Approval for Reverse Stock Split at Stockholders’ Meeting
07:48am
MT
Tilray Brief: Announcing Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders
07:10am
MT
Tilray Brands Announces Proposed Reverse Stock Split And Corresponding Special Meeting Of Stockholders
07:04am
RE
Piper Sandler on Tilray: Canadian Cannabis Still Pressured, Guidance Lowered
Apr. 09
MT
TSX hits eight-month low on potential trade war escalation
Apr. 08
RE
Toronto Stocks Rally; Barrick Gold Shares Up on Pakistan Gold Mine Project
Apr. 08
DJ
Tilray Brands, Inc., Q3 2025 Earnings Call, Apr 08, 2025
Apr. 08
Tilray Shares Down 3.3% in U.S. Pre-market as Fiscal Q3 Loss Rises
Apr. 08
MT
Stock Futures Rebound Pre-Bell Following Tariff-Driven Sell-Off; Levi Strauss, Broadcom Rise
Apr. 08
MT
Earnings Flash (TLRY.TO) Tilray Brands Reports Q3 Revenue US$185.78 Million; Confirms No Current Impact of Tariffs
Apr. 08
MT
Tilray Brands, Inc. Revises Revenue Guidance for the Fiscal Year 2025
Apr. 08
CI
Tilray Brands, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025
Apr. 08
CI
High just got higher: Trump tariffs to raise prices for US cannabis users
Apr. 03
RE
Tilray Brands Wins Hexo Shareholder Lawsuit
Mar. 26
MT
Tilray Up 0.3% In US After Hours On Dismissal of HEXO Shareholder Lawsuit
Mar. 26
MT
Tilray Brief: Co Gets Notice On Nasdaq Listing Rule That Requires Listed Securities to Maintain a Minimum Bid Price of US$1.00 Per Share; Closed at US$0.6816 Today
Mar. 25
MT
Tilray Brief: Tilray Wellness Collaborating with Whole Foods Market to Relaunch Energy Drinks into National US Retail
Mar. 24
MT
Tilray Wellness Collaborates with Whole Foods Market to Relaunch Hi*Ball Energy Drinks into National US Retail
Mar. 24
CI
Tilray Increases Distribution of Non-Alcoholic Craft Beer Line
Mar. 12
MT
Tilray Beverages Announces Distribution Expansion for Runner’s High Brewing
Mar. 12
CI
Toronto Stocks Edge Lower; Auto-Parts Makers Down on Trump Tariff Threats
Mar. 11
DJ
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
Employees
2,650
Sector
Calendar
Ratings
ESG MSCI
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
0.4758USD
Average target price
1.306USD
Spread / Average Target
+174.52%
Quarterly revenue – Rate of surprise
News Tilray Brands, Inc.Tilray Brands Subsidiary Introduces Cannabis Edibles in Australia; Tilray Seeks Approval for Reverse Stock Split
“}]] [[{“value”:”Tilray Brands subsidiary Tilray Medical said Thursday its medical cannabis edibles called Good Supply Pastilles are now available to patients in Australia.
The launch marks Tilray Medical’s first…”}]] Read More
